FdaApplication
ANDA 202365
Identifiers
- fda_app_no: ANDA202365
Properties
| Property | Value |
|---|---|
| applicant_name | WATSON LABS INC |
| application_type | ANDA |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE | SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE | 50MG;1000MG | TABLET;ORAL |
| SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE | SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE | 50MG;500MG | TABLET;ORAL |
2 products